BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 12882056)

  • 1. B-type natriuretic peptide testing in a nurse-led heart failure clinic.
    Coady E
    Nurs Times; 2003 Jul 8-14; 99(27):44-5. PubMed ID: 12882056
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Serum biomarkers for heart failure.
    Jarolim P
    Cardiovasc Pathol; 2006; 15(3):144-9. PubMed ID: 16697927
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cost effectiveness of the B type natriuretic peptide, electrocardiography, and portable echocardiography for the assessment of patients from the community with suspected heart failure.
    Lim TK; Dwivedi G; Hayat S; Collinson PO; Senior R
    Echocardiography; 2007 Mar; 24(3):228-36. PubMed ID: 17313633
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Evaluating the effect of setting up a nurse-led heart failure service.
    Ayers N
    Nurs Times; 2005 Jan 11-17; 101(2):34-6. PubMed ID: 15688920
    [TBL] [Abstract][Full Text] [Related]  

  • 5. N-terminal pro-B-type natriuretic peptide testing improves the management of patients with suspected acute heart failure: primary results of the Canadian prospective randomized multicenter IMPROVE-CHF study.
    Moe GW; Howlett J; Januzzi JL; Zowall H;
    Circulation; 2007 Jun; 115(24):3103-10. PubMed ID: 17548729
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Biomarkers in heart failure management.
    Isaac DL
    Curr Opin Cardiol; 2008 Mar; 23(2):127-33. PubMed ID: 18303525
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The role of b-type natriuretic peptide in heart failure management.
    Newton PJ; Betihavas V; Macdonald P
    Aust Crit Care; 2009 Aug; 22(3):117-23. PubMed ID: 19589695
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [B-type natriuretic peptide as a predictor of sudden death in chronic heart insufficiency].
    Mikkelsen KV; Haghfelt TH
    Ugeskr Laeger; 2003 Mar; 165(13):1371-2. PubMed ID: 12703288
    [No Abstract]   [Full Text] [Related]  

  • 9. A nurse-led approach to secondary prevention of CHD in primary care.
    Clare SA; Sandys MP
    Prof Nurse; 2002 Sep; 18(1):38-41. PubMed ID: 12238720
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Letter by Chung et al regarding article, "N-terminal pro B-type natriuretic peptide testing improves the management of patients with suspected acute heart failure: primary results of the Canadian Prospective Randomized Multicenter IMPROVE-CHF study".
    Chung T; Sindone A; Freedman SB
    Circulation; 2008 Jan; 117(1):e5; author reply e6. PubMed ID: 18172041
    [No Abstract]   [Full Text] [Related]  

  • 11. B-type natriuretic peptide in heart failure.
    Foote RS; Pearlman JD
    N Engl J Med; 2002 Dec; 347(24):1976-8; author reply 1976-8. PubMed ID: 12479193
    [No Abstract]   [Full Text] [Related]  

  • 12. [Diagnosis of heart failure with the help of natriuretic peptides. Practical tool in primary health care].
    Theodorsson E
    Lakartidningen; 2001 Oct; 98(41):4427. PubMed ID: 11699247
    [No Abstract]   [Full Text] [Related]  

  • 13. [Natriuretic peptides--new diagnostic markers in heart disease].
    Angermann CE; Ertl G
    Herz; 2004 Sep; 29(6):609-17. PubMed ID: 15912436
    [TBL] [Abstract][Full Text] [Related]  

  • 14. B-type natriuretic peptide for diagnosis of heart failure in emergency department patients: a critical appraisal.
    Schwam E
    Acad Emerg Med; 2004 Jun; 11(6):686-91. PubMed ID: 15175210
    [TBL] [Abstract][Full Text] [Related]  

  • 15. N-terminal pro-atrial natriuretic peptide (N-ANP) and N-terminal pro-B-type natriuretic peptide (N-BNP) in the prediction of death and heart failure in unselected patients following acute myocardial infarction.
    Squire IB; O'Brien RJ; Demme B; Davies JE; Ng LL
    Clin Sci (Lond); 2004 Sep; 107(3):309-16. PubMed ID: 15182235
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparison of midregional pro-atrial natriuretic peptide with N-terminal pro-B-type natriuretic peptide in predicting survival in patients with chronic heart failure.
    von Haehling S; Jankowska EA; Morgenthaler NG; Vassanelli C; Zanolla L; Rozentryt P; Filippatos GS; Doehner W; Koehler F; Papassotiriou J; Kremastinos DT; Banasiak W; Struck J; Ponikowski P; Bergmann A; Anker SD
    J Am Coll Cardiol; 2007 Nov; 50(20):1973-80. PubMed ID: 17996563
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Impact of the history of congestive heart failure on the utility of B-type natriuretic peptide in the emergency diagnosis of heart failure: results from the Breathing Not Properly Multinational Study.
    Strunk A; Bhalla V; Clopton P; Nowak RM; McCord J; Hollander JE; Duc P; Storrow AB; Abraham WT; Wu AH; Steg G; Perez A; Kazanegra R; Herrmann HC; Aumont MC; McCullough PA; Maisel A
    Am J Med; 2006 Jan; 119(1):69.e1-11. PubMed ID: 16431187
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Ruling out heart failure in primary-care: the cost-benefit of pre-screening using NT-proBNP and QRS width.
    Goode KM; Clark AL; Cleland JG
    Int J Cardiol; 2008 Nov; 130(3):426-37. PubMed ID: 18178273
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Heart failure marker in blood. Diagnosis in 15 minutes].
    MMW Fortschr Med; 2002 Apr; 144(14):6. PubMed ID: 12014287
    [No Abstract]   [Full Text] [Related]  

  • 20. B-type natriuretic peptides: applications for heart failure management in 2005.
    Troughton RW; Richards M
    Intern Med J; 2005 Jul; 35(7):377-9. PubMed ID: 15958104
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.